Transcription factor helps tumors grow in low oxygen, resist anticancer therapies

An international team of researchers led by Keiji Tanimoto found how cancer cells respond to DNA damage signaling when in low oxygen, or hypoxia. Through comprehensive gene expression analyses, the team determined how one family of genes controls DNA damage response, as well as how they weaken the effectiveness of anticancer therapies.

What feeling does this article give you?
Joy
Disgust
Fear
Anger
Sadness

#hashtags to follow:

Keiji Tanimoto [+]   

More #news: